Contact
Please use this form to send email to PR contact of this press release:
FDA Grants Passage Bio Orphan Drug Designation for PBGM01 for Treatment of Infantile GM1 Gangliosidosis
TO:
Please use this form to send email to PR contact of this press release:
FDA Grants Passage Bio Orphan Drug Designation for PBGM01 for Treatment of Infantile GM1 Gangliosidosis
TO: